Taren Grom
Editor-in-Chief Emeritus | LinkedInIn 2001, Taren Grom co-founded PharmaVoice, a business-to-business trade publication, which covers the trends and opportunities facing the life sciences industry from molecule to market, and PharmaLinx LLC, a multimedia publishing company. For more than 20 years, Grom served as editor-in-chief, overseeing the annual PharmaVoice 100, the Woman of the Week podcast series, virtual panels and industry-related events. In September 2021, PharmaVoice was acquired by Industry Dive, and Grom now serves as editor-in-chief emeritus of the newly relaunched PharmaVoice, charged with overseeing special projects, virtual panels, the PharmaVoice 100 and WoW podcast. Grom has been a dedicated volunteer to the Healthcare Businesswomen’s Association for more than a decade, serving on multiple committees, including those responsible for the Annual Conference, Woman of the Year event, the Gender Parity Collaborative and Executive Women’s Forum. Grom served on the organization’s corporate board of directors for nine years. She won the prestigious HBA President’s Award in 2013 and STAR volunteer award in 2019.
145 articles by Taren Grom
-
How Sanofi is taking a ‘creative’ approach to dealmaking
June 23, 2023 -
10 years proud: Pharma’s top companies for LGBTQ+ inclusivity
June 22, 2023 -
Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy
June 21, 2023 -
Shaking up pharma: Change that leaders would like to see
June 16, 2023 -
Woman of the Week: Gamida Cell’s Abbey Jenkins
June 14, 2023 -
Ranking reveals biopharma’s most innovative companies
June 7, 2023 -
Woman of the Week: Marinus Pharmaceuticals’ Christy Shafer
June 7, 2023 -
A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking
June 2, 2023 -
Woman of the Week: Mirati Therapeutics’ Laurie Stelzer
May 31, 2023 -
The ‘superpowers’ pharma leaders should cultivate
May 26, 2023 -
Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi
May 24, 2023 -
The cell ‘atlasing’ approach pushing the limits of drug discovery
May 24, 2023 -
How biopharma executives fight burnout
May 19, 2023 -
Woman of the Week: Genentech’s Veronica Sandoval
May 17, 2023 -
Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall
May 10, 2023 -
AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’
May 10, 2023 -
How Immunocore’s Bahija Jallal embraced the ‘a-ha’ moment of promising science
May 5, 2023 -
Woman of the Week: Jazz Pharmaceuticals’ Neena Patil
May 3, 2023 -
A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient
May 1, 2023 -
5 minutes with — DTRA’s Dr. Amir Kalali
April 28, 2023 -
Woman of the Week: Trevi Therapeutics’ Jennifer Good
April 26, 2023 -
The 99 seconds that changed this CEO’s life
April 21, 2023 -
Woman of the Week: Brii Biosciences’ Ellee de Groot
April 19, 2023 -
5 minutes with — Genlantis Diagnostics’ Ahsan Awan
April 14, 2023 -
Woman of the Week: uMotif’s Julia Lakeland
April 12, 2023